{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Zebulon",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74742",
      "recalling_firm": "GlaxoSmithKline, LLC",
      "address_1": "1011 N Arendell Ave",
      "address_2": "N/A",
      "postal_code": "27597-2309",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and PR.",
      "recall_number": "D-1444-2016",
      "product_description": "Bactroban Nasal, (Mupirocin Calcium Ointment 2%), 1 gram Single Use Tubes, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0029-1526-11.",
      "product_quantity": "153,119 tubes",
      "reason_for_recall": "Penicillin Cross Contamination",
      "recall_initiation_date": "20160718",
      "center_classification_date": "20160720",
      "termination_date": "20170809",
      "report_date": "20160727",
      "code_info": "Lot #: C686801, C689267, C692405, Exp. Jul 2016;  C698116, Exp. Sep 2016;  C750793, C750794, C752166, C752805 and C754828, Exp. Nov 2017.",
      "more_code_info": ""
    }
  ]
}